Disclosed herein are systems and methods for processing waste egg shells into (i) a first product including calcified egg shell particles having diameters of 3μ or less, and (ii) a second product including calcified egg shell particles having diameters in a range from about 3μ to about 7μ. The first product may be used as a CaCO.sub.3 substitute for paint compositions and plastics compositions. The second product may be used as a CaCO.sub.3 blasting media substitute for use with abrasive blasting equipment.

The present invention relates to a kit for indirect production of composite inlays, comprising a polymerizable material for production of a dental model, a polymerizable material for production of an inlay, a polymerizable material for luting of a crosslinked and non-sand-blasted, non-silanized, non-etched, non-primed and non-roughened composite inlay, the surfaces of which have been fully polymerized, in the cavity. Also disclosed is a polymerizable material for increasing the bond strength between the polymerizable material for luting of a crosslinked non-sand-blasted, non-silanized, non-etched, non-primed and non-roughened composite inlay, the surfaces of which have been fully polymerized, in the cavity, and the hard substance of the tooth, and an acid solution for surface etching of the hard substance of the tooth. The invention further relates to methods for producing a composite inlay.

The present invention relates to a curable dental material, to a cured dental material producible therefrom by polymerization, to a method for producing the curable or cured dental material and to the use of the curable or cured dental material.

The invention relates to a highly flowable crosslinkable medical or dental composition comprising a crosslinkable compound, a polymerization initiator and a heterogeneous radiopacifier. Also described is a crosslinked polymer composition obtainable by crosslinking said highly flowable, crosslinkable medical or dental composition and the use of said highly flowable crosslinkable medical or dental composition to fill cavities or hollow structures in human or animal subjects.

The invention relates to a highly flowable crosslinkable medical or dental composition comprising a crosslinkable compound, a polymerization initiator and a heterogeneous radiopacifier. Also described is a crosslinked polymer composition obtainable by crosslinking said highly flowable, crosslinkable medical or dental composition and the use of said highly flowable crosslinkable medical or dental composition to fill cavities or hollow structures in human or animal subjects.

The present application is directed to a dental material and a method of using the dental material. The dental material can include a hardenable resin; an initiator system; a filler; and from about 1 wt % to about 20 wt % zinc compound, based on the weight of the hardenable resin. The contrast ratio of the cured dental material increases by at least about 10 units after continuous exposure to an aqueous solution for 21 days

A solid freeform fabrication material set includes a first solid freeform fabrication liquid material including a solvent, a resin A soluble in the solvent, and an inorganic particle; and a second solid freeform fabrication liquid material including a resin B soluble in water and a second colorant.

Provided is a dental curable composition containing: (A) a porous organic-inorganic composite filler which comprises an organic resin component obtained by polymerizing a polymerizable monomer component (a) including at least 50 mass % of a polymerizable monomer having a hydrogen-bonding functional group, and an inorganic component composed of a plurality of inorganic particles; (B) a polymerizable monomer component including at least 10 mass % of a polymerizable monomer having a hydrogen-bonding functional group; and (C) a polymerization initiator, wherein (C) the polymerization initiator comprises, as photopolymerization initiators, (c1) a photosensitizer compound, (c2) a reducing agent, and (c3) a photoacid generator composed of an aryliodonium salt compound, and the content of the aryliodonium salt compound is 0.1-5 parts by mass with respect to 100 parts by mass of the total mass of (B) the polymerizable monomer component.

A biocompatible composite material for controlled release is disclosed, comprising a biocompatible metal oxide structure with a loaded network of pores. The pore network of the biocompatible composite material is filled with a uniformly distributed biologically active micellizing amphiphilic molecule, the size of these pores ranging from about 0.5 to about 100 nanometers. The material is characterized in that when exposed to phosphate-buffered saline (PBS), the controlled release of the active amphiphilic molecule is predominantly diffusion-driven over time.

A biocompatible composite material for controlled release is disclosed, comprising a biocompatible metal oxide structure with a loaded network of pores. The pore network of the biocompatible composite material is filled with a uniformly distributed biologically active micellizing amphiphilic molecule, the size of these pores ranging from about 0.5 to about 100 nanometers. The material is characterized in that when exposed to phosphate-buffered saline (PBS), the controlled release of the active amphiphilic molecule is predominantly diffusion-driven over time.